6. What Treatment Can Patients Seek for NAION ? NORDIC and Quark Pharmaceuticals have partnered to design and conduct a trial to test a new drug that could protect the optic nerve from further damage due to factors related to acute ischemic injury. For more information on the clinical trial, visit our NAION Clinical Trial FAQ page.
Best Answer: With over 200 to 300 different types of cancer there are very few ways to detect the presence of the disease. There are very, very few cancers that can be detected using a blood test. However, some times the blood work will come back as suspicious and the doctor will order further testing to determine what is going on. A blood test is only one tool in the process of diagnosis.
Sept. 22, 2009 (Berlin) -- Two new blood tests may help to make the diagnosis of colon and other gastrointestinal cancers simpler, cheaper, and less unpleasant. The tests, developed by Belgian and German scientists, look for genetic fingerprints of tumor growth in the blood. One test may also help to predict whether cancer is likely to spread. The tests were described here at a joint meeting of the European Cancer Organization (ECCO) and the European Society for Medical Oncology.